Patients diagnosed with tuberculosis at death or who died during therapy: Association with the human immunodeficiency virus

International Journal of Tuberculosis and Lung Disease

Volumn 15, Issue 4, 2011, Pages 465-470

  Marks, Suzanne ^a   Magee, E ^a   Robison, V ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

HIV; Mortality; Tuberculosis

Indexed keywords

ADULT; AGED; AMERICAN INDIAN; ARTICLE; BACTERIUM CULTURE; CAUCASIAN; DIAGNOSTIC PROCEDURE; ETHNIC DIFFERENCE; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HEALTH CARE FACILITY; HISPANIC; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIDRUG RESISTANT TUBERCULOSIS; NEGRO; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SPUTUM SMEAR; THORAX RADIOGRAPHY; TREND STUDY; TUBERCULOSIS CONTROL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; CONTINENTAL POPULATION GROUPS; FEMALE; HIV INFECTIONS; HOMELESS PERSONS; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; RISK FACTORS; SEX FACTORS; SPUTUM; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT; UNITED STATES; YOUNG ADULT;

EID: 79952787871     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.10.0259     Document Type: Article

References (20)

1. Rieder H L, Kelly G D, Bloch A B, et al. Tuberculosis diagnosed at death in the United States. Chest 1991; 100: 678-681.
2. Sterling T R, Zhao Z, Khan A, et al., for the TB Trials Consortium. Mortality in a large tuberculosis treatment trial: modifiable and non-modifiable risk factors. Int J Tuberc Lung Dis 2006; 10: 542-549. (Pubitemid 43667643)
3. Nahid P, Gonzalez L C, Rudoy I, et al. Treatment outcomes of patients with HIV and tuberculosis. Am J Respir Crit Care Med 2007; 175: 1199-1206. (Pubitemid 46855463)
4. Akksilp S, Karnkawinpong O, Wattanaamornkiat W, et al. Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-infected patients, Thailand. Emerg Infect Dis 2007; 13: 1001-1007. (Pubitemid 47048071)
5. Manosuthi W, Chottanapand S, Thongyen S, et al. Survival rate and risk factors of mortality among HIV/tuberculosisc o-infected patients with and without antiretroviral therapy. J Acquir Immune Defic Syndr 2006; 43: 42-46. (Pubitemid 44306486)
6. Dheda K, Lampe F C, Johnson M A, et al. Outcome of HIV-associated TB in the era of highly active antiretroviral therapy. J Infect Dis 2004; 190: 1670-1676. (Pubitemid 39411018)
7. Leonard M K, Larsen N, Drechsler H, Blumberg H, et al. Increased survival of persons with tuberculosis and human immunodeficiency virus infection, 1991-2000. Clin Infect Dis 2002; 34: 1002-1007.
8. Centers of Disease Control and Prevention. Tuberculosis and human immunodeficiency virus infection: recommendations of the Advisory Committee for the Elimination of Tuberculosis (ACET). MMWR 1989; 38: 236-238.
9. Nijhuis E W, Nagelkerken L. Age-related changes in immune reactivity: the influence of intrinsic defects and of a changed composition of the CD4+ T cell. Exp Clin Immunogenet 1992; 9: 195-202. (Pubitemid 23152807)
10. Rao V K, Iademarco E P, Fraser V J, Kollef M H. The impact of comorbidity on mortality following in-hospital diagnosis of tuberculosis. Chest 1998; 114: 1244-1252. (Pubitemid 28527393)
11. Jones J L, Hanson D L, Dworkin M S, DeCock K M, and the Adult/Adolescent Spectrum of HIV Disease Group. HIV-associated tuberculosis in the era of highly active antiretroviral therapy. The adult/adolescent spectrum of HIV disease group. Int J Tuberc Lung Dis 2000; 4: 1026-1031.
12. Antiretroviral Therapy Cohort Collaboration. Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America. Clin Infect Dis 2005; 41: 1772-1782.
13. Badri M, Wilson D, Wood R. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet 2002; 359: 2059-2064. (Pubitemid 34680968)
14. Centers for Disease Control and Prevention. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. MMWR 1998; 47 (RR-20): 26-27.
15. Centers for Disease Control and Prevention. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. 2009; 58: 20-21.
16. Menzies D, Pai M, Comstock G. New tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146: 340-354. (Pubitemid 351650594)
17. Centers for Disease Control and Prevention, National Center for Health Statistics. The autopsy, medicine, and mortality statistics. Vital Health Stat 2001; 3: 1.
18. Hoyert D L, Kung H C, Xu J. Autopsy patterns in 2003. National Center for Health Statistics. Vital Health Stat 2006; 20: 1-27.
19. Sprinson J, Bahl M, Benjamin R, et al. TB death assessment tool in California: development and pilot test. TB Notes 2008; 4.
20. Munsiff S S, Ahuja S D, Driver C R. Public-private collaboration for multidrug-resistant tuberculosis control in New York City. Int J Tuberc Lung Dis 2006; 10: 639-648. (Pubitemid 43845025)